The advantages of choosing antiobsessive therapy according to decision-making functioning / Paolo Cavedini en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 6 (Diciembre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 6 (Diciembre) . - pp. 628-631 Título : The advantages of choosing antiobsessive therapy according to decision-making functioning Tipo de documento: texto impreso Autores: Paolo Cavedini, Autor ; Tommaso Bassi, Autor ; Claudia Zorzi, Autor Fecha de publicación: 2023 Artículo en la página: pp. 628-631 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Toma de decisiones, Terapia con medicamentos, Fluvoxamina, Pruebas neuropsicológicas, Trastorno obsesivo-compulsivo, Risperidona. Resumen: Previous studies stressed the role of decision-making functioning in predicting antiobsessive treatment outcome with serotonin reuptake inhibitors drugs in patients with obsessive-compulsive disorder. Nevertheless, the use of an augmentation strategy with atypical antipsychotic drugs has proved to be effective in obsessive-compulsive patients nonresponding to serotonin reuptake inhibitors treatment. Link: ./index.php?lvl=notice_display&id=30936 [artículo] The advantages of choosing antiobsessive therapy according to decision-making functioning [texto impreso] / Paolo Cavedini, Autor ; Tommaso Bassi, Autor ; Claudia Zorzi, Autor . - 2023 . - pp. 628-631. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 6 (Diciembre) . - pp. 628-631 Palabras clave: Toma de decisiones, Terapia con medicamentos, Fluvoxamina, Pruebas neuropsicológicas, Trastorno obsesivo-compulsivo, Risperidona. Resumen: Previous studies stressed the role of decision-making functioning in predicting antiobsessive treatment outcome with serotonin reuptake inhibitors drugs in patients with obsessive-compulsive disorder. Nevertheless, the use of an augmentation strategy with atypical antipsychotic drugs has proved to be effective in obsessive-compulsive patients nonresponding to serotonin reuptake inhibitors treatment. Link: ./index.php?lvl=notice_display&id=30936

---

1 (1 - 1 / 1)